About the 3rd Annual IOBDLI Forum
Taking place on the first day of ASCO, the 3rd Annual Immuno-Oncology: BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment. Numerous networking opportunities available via an online one-to-one meeting system with dedicated meeting facilities to make the event more transactional.
Plenary Sessions will include:
Confirmed Keynotes Include:
Confirmed Speakers Include:
|